D.E. Shaw & Co’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4M Sell
213,433
-40,103
-16% -$3.13M 0.01% 1276
2025
Q4
$20M Buy
253,536
+40,530
+19% +$3.51M 0.02% 1241
2025
Q3
$19.5M Buy
213,006
+144,714
+212% +$11.8M 0.02% 1192
2025
Q2
$4.46M Sell
68,292
-161,409
-70% -$10.5M ﹤0.01% 2119
2025
Q1
$15.4M Buy
229,701
+33,382
+17% +$1.99M 0.02% 1093
2024
Q4
$10.9M Buy
196,319
+87,698
+81% +$5.03M 0.01% 1440
2024
Q3
$6.48M Buy
108,621
+99,861
+1,140% +$6.09M 0.01% 1752
2024
Q2
$558K Buy
+8,760
New +$569K ﹤0.01% 3562
2022
Q2
Sell
-14,653
Closed -$412K 5322
2022
Q1
$412K Sell
14,653
-21,286
-59% -$794K ﹤0.01% 4481
2021
Q4
$1.66M Buy
35,939
+18,424
+105% +$792K ﹤0.01% 3524
2021
Q3
$575K Sell
17,515
-7,399
-30% -$230K ﹤0.01% 4006
2021
Q2
$873K Sell
24,914
-13,832
-36% -$471K ﹤0.01% 3652
2021
Q1
$1.4M Buy
38,746
+12,286
+46% +$385K ﹤0.01% 2856
2020
Q4
$768K Buy
+26,460
New +$758K ﹤0.01% 3187
2020
Q2
Sell
-16,523
Closed -$673K 3970
2020
Q1
$673K Sell
16,523
-20,482
-55% -$1.09M ﹤0.01% 3028
2019
Q4
$2.28M Buy
37,005
+2,756
+8% +$183K ﹤0.01% 2358
2019
Q3
$2.5M Buy
34,249
+18,892
+123% +$1.41M ﹤0.01% 2196
2019
Q2
$1.26M Buy
15,357
+8,255
+116% +$587K ﹤0.01% 2536
2019
Q1
$501K Buy
7,102
+1,308
+23% +$77K ﹤0.01% 3002
2018
Q4
$261K Buy
5,794
+700
+14% +$36.7K ﹤0.01% 3427
2018
Q3
$288K Buy
+5,094
New +$312K ﹤0.01% 3375
2017
Q1
Hold
0
3273
2016
Q4
Hold
0
3416
2016
Q3
Hold
0
3358
2016
Q2
Hold
0
3328
2015
Q3
Sell
-15,000
Closed -$931K 3711
2015
Q2
$931K Sell
15,000
-21,829
-59% -$1.3M ﹤0.01% 2762
2015
Q1
$2.3M Buy
36,829
+23,429
+175% +$1.43M ﹤0.01% 1897
2014
Q4
$756K Buy
+13,400
New +$591K ﹤0.01% 3035
2014
Q3
Sell
-13,039
Closed -$449K 4084
2014
Q2
$449K Buy
13,039
+3,699
+40% +$116K ﹤0.01% 3615
2014
Q1
$293K Buy
+9,340
New +$248K ﹤0.01% 3918
2013
Q3
Sell
-3,927
Closed -$24K 4271
2013
Q2
$24K Buy
+3,927
New +$27.5K ﹤0.01% 3934

Other funds holding ANIP